510(k) Report

510(k) · Cleared

Cleared

Voxar 3D Enterprise with Cardiametrix

K061326510(k) TraditionalCleared May 25, 200615-day reviewClass II21 CFR 892.2050

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Barcoview Mis Edinburgh · LLZ System, Image Processing, Radiological

Cleared on May 25, 2006 after a 15-day review. FDA’s file for it is a 510(k) statement, which names no predicate. 25 later devices descend from it.

Decided
May 25, 2006
Review
15 days
Class
Class II
Product code
LLZ
Recalls
None
Predicates
0

25 later devices descend from it, 2 citing it directly.

Descendants, by year cleared 2011: 1 descendant cleared2007: 1 descendant cleared2015: 1 descendant cleared2012: 1 descendant cleared2017: 1 descendant cleared2013: 1 descendant cleared2018: 4 descendants cleared2020: 3 descendants cleared2022: 3 descendants cleared2021: 1 descendant cleared2025: 2 descendants cleared2024: 4 descendants cleared2023: 1 descendant cleared2026: 1 descendant cleared20052010201520202025
  1. This deviceK061326 Voxar 3D Enterprise with CardiametrixBarcoview Mis Edinburgh · 2006
  2. Descendant · cites it directly · 20 of its ownK103465 Synapse 3D Cardiac ToolsFujifilm Medical Systems U.S.A, Inc. · 2011
  3. Descendant · 2 generations on · 19 of its ownK120636 Synapse 3D Cardiac ToolsFujifilm Medical System U.S.A., Inc. · 2012
  4. Descendant · 3 generations on · 12 of its ownK171222 Vitrea Software Toshiba Package; VSTP-001AToshibamedical Systems Corporation · 2017
  5. Descendant · 4 generations on · 11 of its ownK173088 Vitrea Software Toshiba Package VSTP-001AToshibamedical Systems Corporation · 2018
  6. Descendant · 4 generations on · 9 of its ownK183013 Vitrea Software Package, VSTP-001ACanon Medical Systems Corporation · 2018

Showing 5 of 25 descendants. See all descendants

Descendants cleared per year

2007: 12011: 12012: 12013: 12015: 12017: 12018: 42020: 32021: 12022: 32023: 12024: 42025: 22026: 1
2007high 4 (2018) · low 0 (2008)2026

Most influential descendants

Showing 5 of 25 · See all
  • K103465Synapse 3D Cardiac ToolsFujifilm Medical Systems U.S.A, Inc. · 2011 · cites it directly20descendants
  • K120636Synapse 3D Cardiac ToolsFujifilm Medical System U.S.A., Inc. · 2012 · 2 generations on19descendants
  • K171222Vitrea Software Toshiba Package; VSTP-001AToshibamedical Systems Corporation · 2017 · 3 generations on12descendants
  • K173088Vitrea Software Toshiba Package VSTP-001AToshibamedical Systems Corporation · 2018 · 4 generations on11descendants
  • K183013Vitrea Software Package, VSTP-001ACanon Medical Systems Corporation · 2018 · 4 generations on9descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K061326Voxar 3D Enterprise with CardiametrixBarcoview Mis Edinburgh2006—
+1K103465Synapse 3D Cardiac ToolsFujifilm Medical Systems U.S.A, Inc.2011—
+2K120636Synapse 3D Cardiac ToolsFujifilm Medical System U.S.A., Inc.2012—
+3K171222Vitrea Software Toshiba Package; VSTP-001AToshibamedical Systems Corporation2017—
+4K173088Vitrea Software Toshiba Package VSTP-001AToshibamedical Systems Corporation2018—
+4K183013Vitrea Software Package, VSTP-001ACanon Medical Systems Corporation2018—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200710
201110
201210
201310
201510
201710
201840
202030
202110
202230
202310
202440
202520
202610
FIG. 1 — Lineage of K061326, 2006–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA 510(k) statement (indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LLZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LLZ device

  1. #1 K230955 syngo Application Softwarescore 21.5 · 11 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA’s file for it is a 510(k) statement, which names no predicate.

What descends from it? (25)

See all 25

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K103465Synapse 3D Cardiac ToolsFujifilm Medical Systems U.S.A, Inc.201120
K070205ZiostationZiosoft, Inc.20073

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K103465 (Fujifilm Medical Systems U.S.A, Inc., 2011) has gone furthest, with 20 descendants of its own.

How does its category compare?

All LLZ devices

LLZ System, Image Processing, Radiological: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · LLZ

58in 2025

2007: 762008: 942009: 702010: 512011: 1062012: 822013: 952014: 782015: 642016: 822017: 782018: 1042019: 742020: 812021: 832022: 652023: 872024: 622025: 582026 (partial year): 45
2007high 106 (2011) · low 51 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LLZ

173in 2025

2007: 36 days median2008: 52 days median2009: 62 days median2010: 98 days median2011: 79 days median2012: 87 days median2013: 84 days median2014: 89 days median2015: 90 days median2016: 90 days median2017: 107 days median2018: 105 days median2019: 107 days median2020: 115 days median2021: 116 days median2022: 137 days median2023: 157 days median2024: 131 days median2025: 173 days median2026 (partial year): 110 days median
2007high 173 (2025) · low 36 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LLZ

11in 2025

2007: 202008: 322009: 212010: 172011: 302012: 122013: 642014: 62015: 162016: 122017: 52018: 72019: 22020: 62021: 32022: 42023: 82024: 62025: 112026 (partial year): 14
2007high 64 (2013) · low 2 (2019)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LLZ

116in 2025

2007: 1522008: 1542009: 1452010: 1452011: 4542012: 2662013: 1,1302014: 15,6312015: 2112016: 2902017: 1042018: 722019: 882020: 822021: 702022: 282023: 262024: 422025: 116
2007high 15,631 (2014) · low 26 (2023)2025

MAUDE reports naming product code LLZ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007763620152
2008945232154
2009706221145
2010519817145
20111067930454
2012828712266
20139584641,130
20147889615,631
2015649016211
2016829012290
2017781075104
2018104105772
201974107288
202081115682
202183116370
202265137428
202387157826
202462131642
20255817311116
20264511014—

What is it indicated for?

The Voxar 3D product family Is a suite of products that Is Intended to provide toads for the reading and review of a DICOM compliant series of medical Images which can be Interpreted as representing a volume of data. These tools are meant for the use of trained medical Imaging professionals to aid in their reading and review of such data. The Voxar 3D product family provides several levels of functionality. Basic analysis tools used on B daily basis…

Read the full statement (279 words)

The Voxar 3D product family Is a suite of products that Is Intended to provide toads for the reading and review of a DICOM compliant series of medical Images which can be Interpreted as representing a volume of data. These tools are meant for the use of trained medical Imaging professionals to aid in their reading and review of such data. The Voxar 3D product family provides several levels of functionality.

Basic analysis tools used on B daily basis, such as 2D review, orthogonal Multi Planar Reconstructions (MPRs), oblique MPRs, curved/cross-curved MPRs, slab MPRs. AvelP, MIP, MinlP. measurements, annotatlons, reporting, and distibution.

Tools for In-depth analysis, such as regional segmentation of anatomical structures within the Image data, endoscopic review. color volume rendering of finite thickness data cross-sections, 3D review of dae volumes, path definition through vascular and other tubular structures. boundary detection, and PET Image analysis.

Specialist tools and worlflow enhancements for specific clinical applications which provide directed wordtlows, custom User Interfaces, and special measurement and reporting functions optimi'zed for the specific clinical applications. Also included are computer-aided detection algorithms which are designed to cue the user on possible structures of interest Specilized clinical applications Include:

Colon Screening (which Is Intended for the screening of patents for colonic polyps, turnours and other lesions using tomographic Colonography),

Vessel Analysis (which is Intended for the qualitative and quantitative analysis of tomographlc anglographic studies to evaluate occlusive and aneurismal diseases and the effectiveness of stents and stent grafts)

Coronary artery analysis (which Is Intended for the qualitative and quantitative analysts of coronary arteries to evaluate-occlusive and aneurismal disease).

Functional cardiac analysis (which Is intended to evaluate the functlonal characteristics of the heart).

Indications for use as stated in the FDA 510(k) statement.

Cite this page

510(k) Report. “K061326: Voxar 3D Enterprise with Cardiametrix.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K061326

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026